Company research
vTv Therapeutics Inc.
CIK 1641489Updated Sep 27, 2026
SecurityVTVT · NASDAQ · equity
VTVT price & chart
Loading TradingView…
NASDAQ:VTVT on TradingView ↗In the news
vTv Therapeutics to Participate in September Investor Conferences ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
4 filing
DEFA14A filing
Show 5 more recent filings
424B2 filing
Other Events
Items 8.01, 9.01
S-8 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 89,899,000Source | 38,266,000Source | 11,018,000Source | 33,238,000Source |
| Property, Plant and Equipment, NetUSD | — | 28,000Source | 117,000Source | 207,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 88,932,000Source | 36,746,000Source | 9,446,000Source | 12,126,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 62,000Source | 102,000Source | 173,000Source |
| Assets, CurrentUSD | 89,893,000Source | 38,113,000Source | 10,657,000Source | 27,094,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 961,000Source | 1,220,000Source | 1,044,000Source | 2,537,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | 125,000Source | 244,000Source | 349,000Source |
| Other Assets, NoncurrentUSD | 6,000Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 25,462,000Source | 23,965,000Source | 29,567,000Source | 27,399,000Source |
| Stockholders’ equity: | ||||
| Retained Earnings (Accumulated Deficit)USD | -326,692,000Source | -299,718,000Source | -281,042,000Source | -265,524,000Source |
| Stockholders' Equity Attributable to ParentUSD | 64,437,000Source | 12,199,000Source | -24,680,000Source | -10,740,000Source |
| Additional Paid in Capital, Common StockUSD | 391,090,000Source | 311,885,000Source | 256,335,000Source | 253,737,000Source |
| Liabilities and EquityUSD | 89,899,000Source | 38,266,000Source | 11,018,000Source | 33,238,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 6,641,000Source | 5,196,000Source | 10,619,000Source | 7,708,000Source |
| Operating Lease, Liability, CurrentUSD | 0Source | 169,000Source | 169,000Source | 154,000Source |
| Accounts Payable, CurrentUSD | 1,132,000Source | 939,000Source | 4,075,000Source | 2,461,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 0Source | 169,000Source | 338,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 0Source | 2,102,000Source | — | — |
| Additional Financial Items | ||||
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | — | 0Source | 6,131,000Source | 16,579,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -31,080,000Source | -22,705,000Source | -25,966,000Source | -25,073,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,775,000Source | 2,757,000Source | 1,578,000Source | 1,272,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | -40,000Source | -71,000Source | 116,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -25,255,000Source | -25,307,000Source | -19,081,000Source | -16,022,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 0Source | 0Source | 4,404,000Source | -21,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 0Source | 0Source | 21,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 51,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 77,441,000Source | 52,607,000Source | 11,997,000Source | 14,754,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 52,186,000Source | 27,300,000Source | -2,680,000Source | -1,289,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 88,932,000Source | 36,746,000Source | 9,446,000Source | 12,126,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 6,000Source | 2,000Source | 14,000Source | 15,000Source |
| Income Taxes Paid, NetUSD | 0Source | 100,000Source | 0Source | 200,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 3,775,000Source | 2,757,000Source | 1,578,000Source | 1,272,000Source |
| DepreciationUSD | 16,000Source | 89,000Source | 90,000Source | 92,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | 0Source | 0Source | 4,245,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -6,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 0Source | -313,000Source | — |
| General and Administrative ExpenseUSD | 14,947,000Source | 13,651,000Source | 11,907,000Source | 12,201,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 100,000Source | 0Source | 200,000Source |
| InterestExpenseNonoperatingUSD | — | 0Source | — | — |
| Investment Income, InterestUSD | 1,870,000Source | 1,565,000Source | 472,000Source | 352,000Source |
| Net Income (Loss) Attributable to ParentUSD | -26,974,000Source | -18,462,000Source | -20,250,000Source | -19,164,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -4,106,000Source | -4,243,000Source | -5,716,000Source | -5,909,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -26,974,000Source | -18,462,000Source | -20,250,000Source | -19,164,000Source |
| Operating ExpensesUSD | 32,808,000Source | 25,197,000Source | 25,502,000Source | 24,558,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,497,000Source | -3,616,000Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 2,463,000Source | 0Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 16,000Source | — | 0Source | 0Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | 0Source | 0Source | -3,585,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 0Source | 1,017,000Source | 0Source | 2,018,000Source |
| Operating Income (Loss)USD | -32,808,000Source | -24,180,000Source | -25,502,000Source | -22,540,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,497,000Source | -3,616,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -31,080,000Source | -22,605,000Source | -25,966,000Source | -24,873,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 100,000Source | 0Source | 200,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -4,106,000Source | -4,243,000Source | -5,716,000Source | -5,909,000Source |
| Net Income (Loss) Attributable to ParentUSD | -26,974,000Source | -18,462,000Source | -20,250,000Source | -19,164,000Source |
| Interest Expense (non-operating)USD | — | 0Source | — | — |
| Additional Financial Items | ||||
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | 0Source | 0Source | 4,245,000Source | — |
| General and Administrative ExpenseUSD | 14,947,000Source | 13,651,000Source | 11,907,000Source | 12,201,000Source |
| Interest ExpenseUSD | — | — | 13,000Source | 15,000Source |
| InterestExpenseOperatingUSD | 6,000Source | — | — | — |
| Interest Income, OperatingUSD | 0Source | 0Source | 100,000Source | 352,000Source |
| Investment Income, InterestUSD | 1,870,000Source | 1,565,000Source | 472,000Source | 352,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -26,974,000Source | -18,462,000Source | -20,250,000Source | -19,164,000Source |
| Operating ExpensesUSD | 32,808,000Source | 25,197,000Source | 25,502,000Source | 24,558,000Source |
| Research and Development ExpenseUSD | 17,861,000Source | 11,546,000Source | 13,595,000Source | 12,357,000Source |